61 related articles for article (PubMed ID: 21501282)
1. Birth defect rates in women using Adalimumab (Humira(®) ) to treat immunologic-based infertility in IVF patients.
Winger EE; Reed JL; Ashoush S; El-Toukhy T; Ahuja S; Taranissi M
Am J Reprod Immunol; 2011 Sep; 66(3):237-41. PubMed ID: 21501282
[TBL] [Abstract][Full Text] [Related]
2. Degree of TNF-α/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG.
Winger EE; Reed JL; Ashoush S; El-Toukhy T; Ahuja S; Taranissi M
Am J Reprod Immunol; 2011 Jun; 65(6):610-8. PubMed ID: 21223418
[TBL] [Abstract][Full Text] [Related]
3. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF.
Winger EE; Reed JL; Ashoush S; Ahuja S; El-Toukhy T; Taranissi M
Am J Reprod Immunol; 2009 Feb; 61(2):113-20. PubMed ID: 19055656
[TBL] [Abstract][Full Text] [Related]
4. Elevated preconception CD56+ 16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF.
Winger EE; Reed JL; Ashoush S; El-Toukhy T; Ahuja S; Taranissi M
Am J Reprod Immunol; 2011 Nov; 66(5):394-403. PubMed ID: 21623994
[TBL] [Abstract][Full Text] [Related]
5. Die-off ratio correlates with increased TNF-α:IL-10 ratio and decreased IVF success rates correctable with humira.
Winger EE; Reed JL; Ashoush S; El-Toukhy T; Taranissi M
Am J Reprod Immunol; 2012 Nov; 68(5):428-37. PubMed ID: 22845061
[TBL] [Abstract][Full Text] [Related]
6. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion.
Winger EE; Reed JL
Am J Reprod Immunol; 2008 Jul; 60(1):8-16. PubMed ID: 18422811
[TBL] [Abstract][Full Text] [Related]
7. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
[TBL] [Abstract][Full Text] [Related]
8. [In vitro fertilization versus intracytoplasmic sperm injection for primary and secondary infertility using sibling oocytes: clinical analysis of the outcomes].
Shi XY; Wu FR; Chen SL; Wang QL; Luo C; Ni YP; Zheng HY; Qiu ZL; Zhang WQ; Yang J; Chen X
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2263-6. PubMed ID: 20965820
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of pregnancy outcomes after in vitro fertilization-embryo transfer and intracytoplasmic sperm injection].
Lin WQ; Lin JJ; Ye BL; Chen YQ; Zhao JZ; Zhou Y; Chi HH
Zhonghua Fu Chan Ke Za Zhi; 2004 Feb; 39(2):108-11. PubMed ID: 15059589
[TBL] [Abstract][Full Text] [Related]
10. Effect of maternal age on the outcomes of in vitro fertilization and embryo transfer (IVF-ET).
Yan J; Wu K; Tang R; Ding L; Chen ZJ
Sci China Life Sci; 2012 Aug; 55(8):694-8. PubMed ID: 22932885
[TBL] [Abstract][Full Text] [Related]
11. Serial estimation of Th1:th2 cytokines profile in women undergoing in-vitro fertilization-embryo transfer.
Kalu E; Bhaskaran S; Thum MY; Vishwanatha R; Croucher C; Sherriff E; Ford B; Bansal AS
Am J Reprod Immunol; 2008 Mar; 59(3):206-11. PubMed ID: 18275514
[TBL] [Abstract][Full Text] [Related]
12. Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome.
Ming L; Liu P; Qiao J; Lian Y; Zheng X; Ren X; Huang J; Wu Y
Reprod Biomed Online; 2012 May; 24(5):527-31. PubMed ID: 22480904
[TBL] [Abstract][Full Text] [Related]
13. Septate, subseptate and arcuate uterus decrease pregnancy and live birth rates in IVF/ICSI.
Tomaževič T; Ban-Frangež H; Virant-Klun I; Verdenik I; Požlep B; Vrtačnik-Bokal E
Reprod Biomed Online; 2010 Nov; 21(5):700-5. PubMed ID: 20864409
[TBL] [Abstract][Full Text] [Related]
14. Increased pregnancy rates after IVF/ET with intravenous immunoglobulin treatment in women with elevated circulating C56+ cells.
Coulam CB; Goodman C
Early Pregnancy (Cherry Hill); 2000 Apr; 4(2):90-8. PubMed ID: 11723539
[TBL] [Abstract][Full Text] [Related]
15. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcome after IVF and ICSI in unexplained, endometriosis-associated and tubal factor infertility.
Omland AK; Abyholm T; Fedorcsák P; Ertzeid G; Oldereid NB; Bjercke S; Tanbo T
Hum Reprod; 2005 Mar; 20(3):722-7. PubMed ID: 15591078
[TBL] [Abstract][Full Text] [Related]
17. Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles.
Belva F; Henriet S; Van den Abbeel E; Camus M; Devroey P; Van der Elst J; Liebaers I; Haentjens P; Bonduelle M
Hum Reprod; 2008 Oct; 23(10):2227-38. PubMed ID: 18628260
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of oocyte cryopreservation: a meta-analysis.
Oktay K; Cil AP; Bang H
Fertil Steril; 2006 Jul; 86(1):70-80. PubMed ID: 16818031
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of blastogenesis birth defects, arising in the first 4 weeks of pregnancy, after assisted reproductive technologies.
Halliday JL; Ukoumunne OC; Baker HW; Breheny S; Jaques AM; Garrett C; Healy D; Amor D
Hum Reprod; 2010 Jan; 25(1):59-65. PubMed ID: 19850591
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effects of oocyte cryopreservation in assisted reproduction technology].
Wang W; Yan ZJ; Cai LB; Chai DC; Liu CZ; Mao YD; Liu JY
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2755-8. PubMed ID: 19080449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
